J, G., A, v. R., P, G., FW, A., & M, L. (2026). Heart failure in patients with acute myeloid leukemia (AML) treated with anthracycline agents during remission induction therapy: A systematic review and meta-analysis. Leukemia, 40(1), 120. https://doi.org/10.1038/s41375-025-02753-w
Chicago Style (17th ed.) CitationJ, Geels, van Rhenen A, Gradowska P, Asselbergs FW, and Linschoten M. "Heart Failure in Patients with Acute Myeloid Leukemia (AML) Treated with Anthracycline Agents During Remission Induction Therapy: A Systematic Review and Meta-analysis." Leukemia 40, no. 1 (2026): 120. https://doi.org/10.1038/s41375-025-02753-w.
MLA (9th ed.) CitationJ, Geels, et al. "Heart Failure in Patients with Acute Myeloid Leukemia (AML) Treated with Anthracycline Agents During Remission Induction Therapy: A Systematic Review and Meta-analysis." Leukemia, vol. 40, no. 1, 2026, p. 120, https://doi.org/10.1038/s41375-025-02753-w.